Every SEC Form 3/4/5 on record for this filer (CIK 1560782) — 6 issuers, 60 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Director | 2019-07-01 → 2026-06-18 | 11 | −$14M |
| ACAD | ACADIA PHARMACEUTICALS INC | Director | 2016-01-11 → 2026-06-01 | 17 | −$3M |
| CYTK | CYTOKINETICS INC | Director | 2025-08-20 → 2026-05-27 | 5 | — |
| HALO | HALOZYME THERAPEUTICS, INC. | Director · lapsed | 2016-03-08 → 2023-08-15 | 12 | −$2M |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Director · lapsed | 2016-05-19 → 2023-01-05 | 14 | — |
| CMRX | CHIMERIX INC | Director · lapsed | 2016-06-28 → 2019-06-24 | 4 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| ACAD | 2025-11-10 | Sell | 30,000 | $22.37 | $671,100 | 4,041 |
4 of 6 issuers are covered and open a security page; the rest are on file here only.